HOLOGIC INC (HOLX)
US4364401012 - Common Stock
Hologic adds to breast surgery tech with $310M acquisition
Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
How You Should Play Hologic (HOLX) Ahead of Q2 Earnings
Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.
Stay Ahead of the Game With Hologic (HOLX) Q2 Earnings: Wall Street's Insights on Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog.
Hologic (HOLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
Hologic (HOLX) reachead $75.36 at the closing of the latest trading day, reflecting a -0.03% change compared to its last close.
This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger
Illumina chairman and Hologic CEO Stephen MacMillan is no stranger to dealing with well-known activist investors.
Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth
Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.
Agree To Purchase Hologic At $55, Earn 1.6% Annualized Using Options
Biotech Innovations Paving the Way in Breast Cancer Fight
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END
Biotech Innovations Paving the Way in Breast Cancer Fight
/PRNewswire/ -- USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases,...
Hologic (HOLX) Stock Moves -0.05%: What You Should Know
Hologic (HOLX) reachead $76.08 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
Hologic (HOLX) Ascends While Market Falls: Some Facts to Note
Hologic (HOLX) closed at $75.65 in the latest trading session, marking a +0.52% move from the prior day.
Analyst Favorites With Strong Buyback Activity: Hologic Ranks As a Top Pick
Hologic's (HOLX) BCI Genomic Test Study Outcome Favorable
Hologic's (HOLX) BCI test is the only genomic test that is approved by various national oncology guidelines.
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
HOLX Makes Notable Cross Below Critical Moving Average
UPDATE 1-FDA warns of potential risk from Hologic's devices implanted in soft tissue
The U.S. health regulator on Tuesday warned patients and healthcare providers about the potential risk of serious complications arising from the use of Hologic's devices that are implanted in soft tissue. The company's devices, BioZorb Marker and BioZorb LP Marker, are implanted in soft tissue, including breast tissue, where the site needs to be marked for future procedures, such as radiation for breast cancer treatment. The Food and Drug Administration said it has received reports on complications related to the use of the devices in breast tissue including infection, fluid buildup, device moving out of its position and breaking through the skin.
Hologic to Unveil Groundbreaking AI Research at ECR 2024
Hologic to Webcast Presentations at Upcoming Investor Conferences
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic (HOLX) Introduces Genius Digital Diagnostics System
Hologic's (HOLX) Genius Digital Diagnostics System will assist laboratories and healthcare providers with the information needed to make more timely and successful treatment decisions for patients.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
7 Mutual Funds That Will Outperform in Any Market
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds.